Renal Cancer - Results from #2420

Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts. November 10, 2020

Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells. November 9, 2020

MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma. November 9, 2020

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits. November 9, 2020

Identified a Biomarker That Predicts the Increase in Malignancy That Antiangiogenic Therapy Can Cause in Kidney Cancers November 6, 2020

Kidney Cancer PDOXs Reveal Patient‐specific Pro‐malignant Effects of Antiangiogenics and Its Molecular Traits November 6, 2020

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. November 6, 2020

Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma. November 6, 2020

Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma. November 6, 2020

Association of Hepatitis C Infection and Risk of Kidney Cancer: A Systematic Review and Meta-analysis of Observational Studies. November 5, 2020

Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma. November 5, 2020

Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma. November 5, 2020

Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors. November 4, 2020

CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC). November 4, 2020

Current updates and future perspectives on the management of renal cell carcinoma. November 4, 2020

Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma. November 4, 2020

Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study. November 3, 2020

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer. November 3, 2020

Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance. November 3, 2020

BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma. November 2, 2020

Page 122 of 458